Pre-hospital antiplatelet medication use on COVID-19 disease severity-Reference-Cited by-同舟云学术

Pre-hospital antiplatelet medication use on COVID-19 disease severity

Published:2021-09 Issue:5 Volume:50 Page:618-621
ISSN:0147-9563
Container-title:Heart & Lung
language:en
Short-container-title:Heart & Lung

Author:

Pan Darren,Ip Ada,Zhan Serena,Wasserman Isaac,Snyder Daniel J.,Agathis Alexandra Z.,Shamapant Nikhil,Yang Jeong Yun,Pai Akila,Mazumdar Madhu,Poor Hooman

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference20 articles.

1. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study;Zhou;Lancet,2020

2. Covid-19 does not lead to a “typical” acute respiratory distress syndrome;Gattinoni;Am J Respir Crit Care Med,2020

3. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19;Ackermann;N Engl J Med,2020

4. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia;Tang;J Thromb Haemost,2020

5. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases;Magro;Transl Res,2020

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impacto del uso previo de antiagregantes plaquetarios en la susceptibilidad, la progresión y la gravedad de la COVID-19: un estudio poblacional;Revista Española de Cardiología;2024-07

2. Impact of prior use of antiplatelets on COVID-19 susceptibility, progression, and severity: a population-based study;Revista Española de Cardiología (English Edition);2024-07

3. Effects of Proton Pump Inhibitors on Cardiovascular Events and Inflammatory Factors in Patients With Upper Gastrointestinal Bleeding Undergoing Dual Antiplatelet Therapy;Cureus;2024-05-08

4. Efficacy and safety of proton pump inhibitors on cardiovascular events and inflammatory factors in patients with upper gastrointestinal bleeding undergoing dual antiplatelet therapy;Inflammopharmacology;2024-04-20

5. Comment on “Pre-hospital antiplatelet medication use on COVID-19 disease severity”;Heart & Lung;2023-03